Table 1.
Total, N = 22 | |
Age (yrs), mean (range) | 47.5 (36–62) |
Clinical stage | |
Tumor stage, no. (%) | |
T1 | 2 (9.1) |
T2 | 13 (59.1) |
T3–T4 | 7 (31.8) |
Nodal stage, no. (%) | |
N1 | 15 (68.2) |
N2 | 4 (18.2) |
N3 | 3 (13.6) |
Hormone receptor status, no. (%) | |
Positive | 7 (31.8) |
Negative | 15 (68.2) |
Histologic grade, no. (%) | |
G1 | 0 (0) |
G2 | 19 (86.4) |
G3 | 3 (13.6) |
Ki-67, no. (%) | |
<10% | 3 (13.6) |
10–20% | 3 (13.6) |
≥20% | 16 (72.7) |
Menopause status, no. (%) | |
Pre-menopause | 12 (54.5) |
Post-menopause | 10 (45.5) |